Trichofolliculoma is a benign skin tumor which is typically found on the face, scalp, and neck. It is a common skin condition that affects both men and women, although it is more commonly seen in women. Trichofolliculoma is characterized by a single, firm, dome-shaped bump with a central pore from which hairs emerge. It is usually painless and is not associated with any other medical conditions. In this article, we will take a closer look at the causes and treatment options for trichofolliculoma.
Trichofolliculoma is a benign skin tumor which is typically found on the face, scalp, and neck. It is a common skin condition that affects both men and women, although it is more commonly seen in women. Trichofolliculoma is characterized by a single, firm, dome-shaped bump with a central pore from which hairs emerge. It is usually painless and is not associated with any other medical conditions.
The exact cause of trichofolliculoma is unknown, but it is believed to be related to an abnormal hair follicle. The abnormal hair follicle is thought to be caused by a combination of genetic and environmental factors. It is believed that the abnormal hair follicle is caused by a mutation in the gene that controls the growth and development of hair follicles. This mutation causes the hair follicle to become enlarged and develop a central pore from which hairs emerge.
Trichofolliculoma is typically diagnosed by a physical exam. The doctor will examine the skin for the characteristic dome-shaped bump with a central pore from which hairs emerge. The doctor may also order additional tests such as a biopsy to confirm the diagnosis.
The treatment for trichofolliculoma typically involves surgical removal of the tumor. The procedure is usually done under local anesthesia and is usually successful in removing the entire tumor. In some cases, the tumor may recur and require additional surgery. In some cases, the doctor may recommend a topical cream or ointment to reduce the size of the tumor. These creams and ointments typically contain retinoids or corticosteroids, which are medications that can reduce inflammation and shrink the tumor. In rare cases, the doctor may recommend radiation therapy to shrink the tumor. This is usually done if the tumor is large or if it is not responding to other treatments.
Trichofolliculoma is a benign skin tumor which is typically found on the face, scalp, and neck. It is a common skin condition that affects both men and women, although it is more commonly seen in women. The exact cause of trichofolliculoma is unknown, but it is believed to be related to an abnormal hair follicle. Trichofolliculoma is typically diagnosed by a physical exam and is usually treated with surgical removal of the tumor. In some cases, topical creams or ointments may be used to reduce the size of the tumor or radiation therapy may be recommended.
1.
Study suggests exercise could reduce breast cancer recurrence
2.
Additional imaging techniques can detect early stage cancers missed by mammograms in women with dense breasts
3.
A paper strip test might enable the early detection of cancer.
4.
Laser Therapy Shows Promise for Brain Tumors
5.
Unexplained CAR-T Death; Americans Spurn Sunscreen; Improving Diversity in Trials
1.
Radiation Oncology: Integrating AI, Theranostics, and Adaptive Therapies for Personalized Cancer Care
2.
Demystifying Lymphocytes: Everything You Need to Know
3.
Adaptive Immune Reprogramming in Advanced Solid Tumors
4.
Emerging Chemo-Immunotherapy: New Agents and Mechanisms in Modern Oncology
5.
Uncovering Breast Cancer: The Power of Early Stage Ultrasound
1.
International Conference on Innovations in Critical Care for Oncology and Cardiology
2.
International Conference on Oncology, Cardiology and Critical Care Policy
3.
International Conference on Oncology, Cancer Prevention and Public Health
4.
International Conference on Cancer Nursing and Rehabilitation Strategies
5.
International Conference on Best Practices in Oncology, Cardiology and Critical Care
1.
Updates on Standard V/S High Risk Myeloma Treatment
2.
The Comprehensive Impact of CDK4/6 Inhibition in HR+/HER2- Metastatic Breast Cancer: Insights from PALOMA-2.
3.
A Panel Discussion on Clinical Trial End Point for Tumor With PPS > 12 months
4.
Experts' Opinion on the Goal of Treatment of Patients with Relapsed Adult B-cell ALL
5.
Deep Dive Into EGFR Mutation Positive Non-Small Cell Lung Cancer
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation